ETF comparison

FHLC vs XBI

Both Healthcare.

Fidelity MSCI Health Care Index ETF · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
13.4 %

119 positions appear in both funds. Buying equal dollars of FHLC and XBI would leave roughly 13.4% of each dollar exposed to the same underlying securities.

FHLC only 86.5% Shared 13.4% XBI only 86.6%
In FHLC only
219 positions
Shared
119 positions
In XBI only
35 positions

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

79 composite / 100
Expense ratio
0.084%
Net assets
$3.22B
TTM yield
1.32%
Top-10 conc.
50.6%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

81 composite / 100
Expense ratio
0.35%
Net assets
$10.73B
TTM yield
0.37%
Top-10 conc.
20.4%

Sub-score comparison

92
Cost
65
83
Tax efficiency
85
79
Liquidity
100
42
Concentration
85
Tracking quality
FHLC sub-score XBI

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

FHLC is 27 bps cheaper than XBI. On a $100,000 position that's about $266/yr more in fees for XBI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with FHLC vs XBI.

Top shared holdings

119 shared in total
# Holding In FHLC In XBI Overlap
1 Regeneron Pharmaceuticals Inc 1.18% 1.14% 1.14%
2 AbbVie Inc 6.03% 1.09% 1.09%
3 Gilead Sciences Inc 2.62% 1.09% 1.09%
4 Amgen Inc 3.01% 1.06% 1.06%
5 Vertex Pharmaceuticals Inc 1.75% 1.03% 1.03%
6 Alnylam Pharmaceuticals Inc 0.66% 1.18% 0.66%
7 Insmed Inc 0.47% 1.34% 0.47%
8 Biogen Inc 0.45% 1.10% 0.45%
9 Natera Inc 0.44% 1.16% 0.44%
10 United Therapeutics Corp 0.38% 1.24% 0.38%
11 Revolution Medicines Inc 0.38% 1.11% 0.38%
12 Moderna Inc 0.26% 1.03% 0.26%

Only in FHLC

219 total
  • Eli Lilly & Co 12.13%
  • Johnson & Johnson 8.94%
  • UnitedHealth Group Inc 5.42%
  • Merck & Co Inc 4.38%
  • Thermo Fisher Scientific Inc 2.91%
  • Intuitive Surgical Inc 2.62%
  • Abbott Laboratories 2.55%
  • Pfizer Inc 2.45%
  • Bristol-Myers Squibb Co 1.99%
  • Danaher Corp 1.84%

Only in XBI

35 total
  • Summit Therapeutics Inc 1.24%
  • Amicus Therapeutics Inc 1.15%
  • Arcellx Inc 1.14%
  • Corvus Pharmaceuticals Inc 0.42%
  • Day One Biopharmaceuticals Inc 0.32%
  • SELLAS Life Sciences Group Inc 0.27%
  • Rigel Pharmaceuticals Inc 0.26%
  • Replimune Group Inc 0.23%
  • Sionna Therapeutics Inc 0.22%
  • Vor BioPharma Inc 0.22%

Open FHLC or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.